# ONE-SHOT (NCT03294889)

> ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer

No report yet. It can be ordered.

- Drugs tested: none (the trial tests a strategy, not a drug)
- Indication: localized prostate cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03294889
- Phase: PHASE1, PHASE2
- Status: RECRUITING
- Sponsor: University Hospital, Geneva
- Conditions: Prostate Cancer
- Interventions: Stereotactic body radition (SBRT)
- Enrollment: 45
- Primary outcome: Clinical performance
- Primary outcome: Progression free survival (PFS)

## Indexed commentary on ONE-SHOT so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 8 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=one-shot-nct03294889

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03294889", "email": "<work email>"}; the inbox owner confirms by the emailed link.